Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global review
SM Tiggelaar, MJ Lin, RP Viscidi, J Ji… - Journal of Adolescent …, 2012 - Elsevier
PURPOSE: Global data on human papillomavirus (HPV) serological and deoxyribonucleic
acid (DNA) prevalence are essential to optimize HPV prophylactic vaccination strategies …
acid (DNA) prevalence are essential to optimize HPV prophylactic vaccination strategies …
Age-specific prevalence of infection with human papillomavirus in females: a global review
JS Smith, A Melendy, RK Rana, JM Pimenta - Journal of Adolescent Health, 2008 - Elsevier
PURPOSE: Global data on age-specific prevalence of human papillomavirus (HPV) infection
overall, and for high-risk HPV types 16 and 18, are essential for the future implementation of …
overall, and for high-risk HPV types 16 and 18, are essential for the future implementation of …
Age-specific prevalence of human papillomavirus infection in males: a global review
JS Smith, PA Gilbert, A Melendy, RK Rana… - Journal of Adolescent …, 2011 - Elsevier
Purpose Global data on age-specific prevalence of human papillomavirus (HPV) infection in
males, especially for oncogenic HPV types 16 and 18, are essential for future efforts to …
males, especially for oncogenic HPV types 16 and 18, are essential for future efforts to …
Declines in vaccine-type human papillomavirus prevalence in females across racial/ethnic groups: data from a national survey
NM McClung, RM Lewis, JW Gargano, T Querec… - Journal of Adolescent …, 2019 - Elsevier
Purpose To monitor human papillomavirus (HPV) vaccine impact in the US, we evaluated
quadrivalent vaccine (4vHPV)-type prevalence among females aged 14–34 years in the …
quadrivalent vaccine (4vHPV)-type prevalence among females aged 14–34 years in the …
Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14–26 year old females in the US
Background Low human papillomavirus (HPV) vaccination rates early after introduction,
particularly among low income and minority adolescents, may have resulted in disparities in …
particularly among low income and minority adolescents, may have resulted in disparities in …
Epidemiology and risk factors for human papillomavirus infection in a diverse sample of low-income young women
T Shikary, DI Bernstein, Y Jin, GD Zimet… - Journal of Clinical …, 2009 - Elsevier
BACKGROUND: Two HPV vaccines prevent infection with HPV-16 and HPV-18, high-risk
(cancer-associated) HPV types which together cause approximately 70% of cervical …
(cancer-associated) HPV types which together cause approximately 70% of cervical …
Incidence and types of human papillomavirus infections in adolescent girls and young women immunized with the human papillomavirus vaccine
NF Schlecht, A Diaz, A Nucci-Sack… - JAMA Network …, 2021 - jamanetwork.com
Importance Rates of human papillomavirus (HPV) infection have decreased since the
introduction of HPV vaccines in populations with high vaccine uptake. Data are limited for …
introduction of HPV vaccines in populations with high vaccine uptake. Data are limited for …
Seroprevalence of human papillomavirus types 16 and 18 in the general population in Taiwan: implication for optimal age of human papillomavirus vaccination
CJ Chen, RP Viscidi, CH Chuang, YC Huang… - Journal of clinical …, 2007 - Elsevier
BACKGROUND: The optimal age for administration of recently approved prophylactic
human papillomavirus (HPV) vaccines remains undetermined. OBJECTIVES: The aim of the …
human papillomavirus (HPV) vaccines remains undetermined. OBJECTIVES: The aim of the …
[HTML][HTML] Age distribution of human papillomavirus infection and neutralizing antibodies in healthy Chinese women aged 18–45 years enrolled in a clinical trial
LH Wei, YY Su, YM Hu, RC Li, W Chen, QJ Pan… - Clinical Microbiology …, 2020 - Elsevier
Objectives Data from clinical trials of human papillomavirus (HPV) vaccines showed that
women naïve (negative for both type-specific antibodies and DNA) to vaccine types would …
women naïve (negative for both type-specific antibodies and DNA) to vaccine types would …
Prevalence of HPV after introduction of the vaccination program in the United States
LE Markowitz, G Liu, S Hariri, M Steinau, EF Dunne… - …, 2016 - publications.aap.org
BACKGROUND: Since mid-2006, human papillomavirus (HPV) vaccination has been
recommended for females aged 11 to 12 years and through 26 years if not previously …
recommended for females aged 11 to 12 years and through 26 years if not previously …